Accelerate Diagnostics, Inc. (AXDXQ)
OTCMKTS · Delayed Price · Currency is USD
0.000001
0.00 (0.00%)
Inactive · Last trade price on Aug 20, 2025
Accelerate Diagnostics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 15.1 | 12.14 | 34.91 | 39.9 | 35.78 |
Short-Term Investments | 1.2 | 1.08 | 10.66 | 23.72 | 32.49 |
Cash & Short-Term Investments | 16.3 | 13.22 | 45.56 | 63.62 | 68.27 |
Cash Growth | 23.29% | -70.99% | -28.38% | -6.81% | -37.05% |
Receivables | 2.04 | 2.62 | 2.42 | 2.32 | 1.55 |
Inventory | 2.85 | 3.31 | 5.19 | 5.07 | 9.22 |
Prepaid Expenses | 0.21 | 0.38 | 0.82 | 0.77 | 1.17 |
Other Current Assets | 0.84 | 4.94 | 2.03 | 1.56 | 1.78 |
Total Current Assets | 22.24 | 24.47 | 56.01 | 73.33 | 81.99 |
Property, Plant & Equipment | 5.82 | 5.08 | 7.76 | 7.9 | 9.32 |
Other Long-Term Assets | 0.5 | 1.82 | 1.24 | 1.82 | 2.12 |
Total Assets | 28.56 | 31.37 | 65.02 | 83.05 | 93.43 |
Liabilities
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Accounts Payable | 4.84 | 4.8 | 4.5 | 1.98 | 1.29 |
Accrued Expenses | 3.02 | 3.41 | 3.15 | 3.76 | 4.25 |
Current Portion of Long-Term Debt | 16.51 | 0.73 | 56.41 | 0.08 | 0.55 |
Current Portion of Leases | 0.63 | 1.56 | 1.94 | 0.67 | 0.5 |
Current Unearned Revenue | 1.64 | 1.55 | 0.55 | 0.45 | 0.38 |
Other Current Liabilities | 4.56 | - | - | - | - |
Total Current Liabilities | 31.2 | 12.03 | 66.56 | 6.95 | 6.97 |
Long-Term Debt | 46.84 | 36.1 | 16.86 | 107.98 | 145.87 |
Long-Term Leases | 2.6 | 0.83 | 2.33 | 2.38 | 3.06 |
Long-Term Unearned Revenue | 2.28 | 1.12 | - | - | - |
Other Long-Term Liabilities | 1.68 | 1.16 | 1.54 | 0.81 | 0.34 |
Total Liabilities | 84.6 | 51.25 | 87.28 | 118.12 | 156.24 |
Shareholders' Equity
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Common Stock | 0.03 | 0.01 | 0.01 | 0.07 | 0.06 |
Additional Paid-In Capital | 707.91 | 694.63 | 630.43 | 580.65 | 475.07 |
Retained Earnings | -718.9 | -668.86 | -607.24 | -570.67 | -492.97 |
Treasury Stock | -45.07 | -45.07 | -45.07 | -45.07 | -45.07 |
Comprehensive Income & Other | -0.01 | -0.61 | -0.4 | -0.06 | 0.09 |
Total Common Equity | -56.04 | -19.89 | -22.27 | -35.08 | -62.81 |
Shareholders' Equity | -56.04 | -19.89 | -22.26 | -35.07 | -62.81 |
Total Liabilities & Equity | 28.56 | 31.37 | 65.02 | 83.05 | 93.43 |
Additional Metrics
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Total Debt | 66.58 | 39.22 | 77.54 | 111.11 | 149.98 |
Net Cash (Debt) | -50.28 | -26 | -31.98 | -47.5 | -81.71 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -2.16 | -2.08 | -3.89 | -7.69 | -14.59 |
Filing Date Shares Outstanding | 25.19 | 21.66 | 9.96 | 6.78 | 5.93 |
Total Common Shares Outstanding | 25.19 | 14.57 | 9.75 | 6.76 | 5.76 |
Working Capital | -8.96 | 12.43 | -10.54 | 66.39 | 75.02 |
Book Value Per Share | -2.22 | -1.37 | -2.28 | -5.18 | -10.90 |
Tangible Book Value | -56.04 | -19.89 | -22.27 | -35.08 | -62.81 |
Tangible Book Value Per Share | -2.22 | -1.37 | -2.28 | -5.18 | -10.90 |
Machinery | 7.85 | 7.59 | 10.52 | 11.83 | 13.28 |
Construction In Progress | 0.22 | 0.11 | 0.11 | 0.68 | - |